Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy.

@article{Westermann2007CardioprotectiveAA,
  title={Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy.},
  author={Dirk Westermann and Sophie Van Linthout and Sameer Dhayat and Nasser Abdalla Dhayat and Felicitas Escher and Carola B{\"u}cker-G{\"a}rtner and Frank Spillmann and Michel Noutsias and A. R. Riad and Heinz-Peter Schultheiss and Carsten Tsch{\"o}pe},
  journal={Diabetes},
  year={2007},
  volume={56 7},
  pages={1834-41}
}
OBJECTIVE We investigated the effect of pharmacological inhibition of the interleukin converting enzyme (ICE) on cardiac inflammation, apoptosis, fibrosis, and left ventricular function in an animal model of diabetes. RESEARCH DESIGN AND METHODS Diabetes was induced in 24 Sprague-Dawley rats by injection of streptozotozin (STZ) (70 mg/kg). Diabetic animals were treated with the interleukin converting enzyme (ICE) inhibitor (ICEI) (n = 12) or with a placebo (n = 12). Nondiabetic rats served as… CONTINUE READING